Trial Profile

Early Access Program with MaaT013 in Acute Graft Versus Host Disease at City of Hope Hospital

Status: Recruiting

Phase of Trial: Clinical Phase Unknown

Latest Information Update: 31 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Maa-T-013 (Primary)
Indications Graft-versus-host disease
Focus Expanded access; Therapeutic Use

Most Recent Events

31 Mar 2025 New trial record
27 Mar 2025 According to the MaaT Pharma Media Release, Company announced the initiation of this expanded program in Dec 2024

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com